Journal Browser

Go Edit a Special Issue


Special Issue Title:

Toxicological Emergencies: Pathophysiology and Management

Deadline for manuscript submissions: 26 January 2022

Print Special Issue Flyer (20)

Special Issue Editor

  • Guest Editor

    Dr. Asmaa El-BannaE-MailWebsite

    Professor of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Alexandria University, Egypt

    Interests: Clinical toxicology, Environmental toxicology, Experimental toxicology, Forensic medicine, Forensic science, Abuse or violence

Special Issue Information

Toxic agents surround us everywhere; in the environment, agriculture, industry, transportation, homes, and schools. Exposure can occur intentionally or non-intentionally.

Critical care physicians should recognize the clinical condition of patients and address the problems quickly. The highest priority should be given to the physicians to protect their safety and health as a result of patient violence or toxin exposure. Patients may exhibit violent or aggressive behavior especially in cases of suicidal attempts or taking alcohol or illicit drugs with altered or confused mental status.

Toxicological emergencies can develop upon toxin exposure as well as exposure to drug overdose, drug interaction in case of co-ingestion or during anesthesia. Patients may experience alterations in acid-base or electrolyte balance or hemodynamic parameters such as a respiratory compromise or cardiovascular collapse. The prognosis usually depends on quantity, duration, and route of exposure, initial decontamination, stabilization, and treatment. Age and pre-existing health conditions can have a profound effect on the outcome of toxic exposure. Group poisoning can indicate a presence of an environmental hazard and investigating these cases can yield valuable information for the protection of society.

This special issue is targeting to present toxicological emergencies and interventions done in these cases, is there any new approach in their management? Are the life-saving measures usually done in primary health care centers or not?

We welcome articles, trials, case reports, case-series expressing any toxicological emergency.


Toxicology, Emergency, Emergency department

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time